[HTML][HTML] The theranostic promise for Neuroendocrine Tumors in the late 2010s-Where do we stand, where do we go?

RA Werner, A Weich, M Kircher, LB Solnes… - Theranostics, 2018 - ncbi.nlm.nih.gov
More than 25 years after the first peptide receptor radionuclide therapy (PRRT), the concept
of somatostatin receptor (SSTR)-directed imaging and therapy for neuroendocrine tumors (…

[HTML][HTML] Trends in incidence and survival in patients with gastrointestinal neuroendocrine tumors: A SEER database analysis, 1977-2016

M Liu, L Wei, W Liu, S Chen, M Guan, Y Zhang… - Frontiers in …, 2023 - frontiersin.org
… used separately from neuroendocrine neoplasms and neuroendocrine neoplasms for the …
WHO classification of digestive tumors is the neuroendocrine tumor classification system (9)…

Neuroendocrine Tumor Theranostics: An Update and Emerging Applications in Clinical Practice

S Sheikhbahaei, MS Sadaghiani… - American Journal of …, 2021 - Am Roentgen Ray Soc
Neuroendocrine tumors (NETs) are a heterogeneous group of tumors derived from
neuroendocrine cells in various organs [1]. NETs can occur in almost any organ, but NETs most …

[HTML][HTML] Early diagnosis and treatment of myocardial neuroendocrine tumor metastasis: the cornerstone role of multimodality imaging

N Mikail, A Pisani, S El Hatimi, O Hentic… - Circulation …, 2021 - Am Heart Assoc
… carcinoid syndrome related to an ileal neuroendocrine tumor (NET). The patient underwent
successful surgical resection of the primary tumor. Histological study confirmed the diagnosis …

Prognostic value of 18F-FDG PET/CT in a large cohort of patients with advanced metastatic neuroendocrine neoplasms treated with peptide receptor radionuclide …

J Zhang, Q Liu, A Singh, C Schuchardt… - Journal of Nuclear …, 2020 - Soc Nuclear Med
… -differentiated SSTR-positive neuroendocrine tumors (5) and is … treatment of
gastroenteropancreatic neuroendocrine tumors. … promise for neuroendocrine tumors in the late

[HTML][HTML] Somatostatin and somatostatin receptors: from signaling to clinical applications in neuroendocrine neoplasms

MI del Olmo-Garcia, S Prado-Wohlwend, A Andres… - Biomedicines, 2021 - mdpi.com
neuroendocrine tumors (NETs) subclassified as G1, G2 and G3 (according proliferative
index and mitotic rate) and poorly differentiated neuroendocrine … It keeps the neuroendocrine

Theranostics in Neuroendocrine Tumors

S Vallabhajosula - Molecular Imaging and Targeted Therapy …, 2023 - Springer
Neuroendocrine neoplasms (NENs) are a heterogeneous group of epithelial neoplastic …
neuroendocrine tumors (NETs) to very aggressive poorly differentiated neuroendocrine

Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors

S Partelli, L Landoni, V Andreasi, C Nessi, F Muffatti… - Surgery, 2020 - Elsevier
… surgery, which is usually slow and can occur late after initial surgery. In fact, the median …
for PanNET were first published in the early 2010s. Surprisingly, in patients who had undergone …

KSNM60 in Nuclear Endocrinology: from the Beginning to the Future

CM Hong, YJ Jeong, HW Kim, BC Ahn - Nuclear Medicine and Molecular …, 2022 - Springer
… glands, pituitary gland, and neuroendocrine tumors (NETs). In … Since the late 1980s, it has
been used to diagnose NETs in … In the 2010s, many changes occurred in how NETs were …

Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours

S Adant, GM Shah, JM Beauregard - European journal of nuclear medicine …, 2020 - Springer
The incidence of neuroendocrine tumours (NETs) is increasing, but curative therapeutic
options are limited because diagnosis is often delayed until the tumour has metastasized. …